Screener
Abbott ABT Nutritional Products — R&D
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Net Sales to External Customers / Three Months Ended June 30, 2026 | Net Sales to External Customers / Three Months Ended June 30, 2025 | Cost of Products Sold / Three Months Ended June 30, 2026 | Cost of Products Sold / Three Months Ended June 30, 2025 | Research and Development / Three Months Ended June 30, 2026 | Research and Development / Three Months Ended June 30, 2025 | Selling, General, and Administrative / Three Months Ended June 30, 2026 | Selling, General, and Administrative / Three Months Ended June 30, 2025 | Operating Earnings / Three Months Ended June 30, 2026 | Operating Earnings / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Established Pharmaceuticals | $1,499 | $1,383 | $(650) | $(631) | $(48) | $(43) | $(419) | $(363) | $382 | $346 |
| Nutritional Products | 2,144 | 2,212 | (1,148) | (1,155) | (54) | (54) | (574) | (585) | 368 | 418 |
| Diagnostic Products | 3,092 | 2,173 | (1,532) | (1,224) | (268) | (154) | (793) | (423) | 499 | 372 |
| Medical Devices | 5,853 | 5,369 | (1,925) | (1,758) | (470) | (430) | (1,489) | (1,385) | 1,969 | 1,796 |
| Total | $12,588 | $11,137 | $(5,255) | $(4,768) | $(840) | $(681) | $(3,275) | $(2,756) | $3,218 | $2,932 |
| Other | 5 | 5 | ||||||||
| Net sales | $12,593 | $11,142 | ||||||||
| Corporate functions and plan benefit costs | (45) | (65) |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's nutritional products — R&D?
- Abbott (ABT) reported nutritional products — R&D of $54M in Q2 2026.
- How has Abbott's nutritional products — R&D changed year-over-year?
- Abbott's nutritional products — R&D decreased by 0.0% year-over-year, from $54M to $54M.
- What is the long-term trend for Abbott's nutritional products — R&D?
- Over 3 years (2022 to 2025), Abbott's nutritional products — R&D has grown at a 3.7% compound annual growth rate (CAGR), from $191M to $213M.
- What does nutritional products — R&D mean?
- Expenditures dedicated to the discovery, clinical testing, and development of new nutritional formulations and product enhancements. This investment is critical for maintaining competitive advantage and meeting evolving regulatory and nutritional standards.
Ask your AI about Abbott's nutritional products — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude